Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
60.14
-2.14 (-3.44%)
At close: Jun 5, 2026, 4:00 PM EDT
60.00
-0.14 (-0.23%)
After-hours: Jun 5, 2026, 6:40 PM EDT
Oruka Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +99.53% | May 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $125 | Buy | Maintains | $125 | +107.85% | May 16, 2026 |
| Wedbush | Wedbush | Buy Maintains $165 | Buy | Maintains | $165 | +174.36% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $75 → $180 | Buy | Maintains | $75 → $180 | +199.30% | May 14, 2026 |
| BTIG | BTIG | Buy Maintains $151 | Buy | Maintains | $151 | +151.08% | May 14, 2026 |
| Barclays | Barclays | Buy Reiterates $160 | Buy | Reiterates | $160 | +166.05% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $109 → $120 | Buy | Maintains | $109 → $120 | +99.53% | Apr 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.